Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Follistatin Isoform Comparison

Understanding the three isoforms clarifies why FS-344 is the preferred injectable form. FS-344 344 Precursor (injected) Strong Cleaved to FS-315 in vivo FS-315 315 Circulation Main muscle-targeting form FS-288 288 Tissue-bound (gonads) Moderate Concentrates in

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Understanding the three isoforms clarifies why FS-344 is the preferred injectable form.
  • FS-344
  • 344
  • Precursor (injected)
  • Strong
  • Cleaved to FS-315 in vivo
  • FS-315
  • 315
  • Circulation
  • Main muscle-targeting form
  • FS-288
  • 288
  • Tissue-bound (gonads)
  • Moderate
  • Concentrates in reproductive tissue
  • FS-344 is preferred for injection because it is more stable as a recombinant protein and converts to FS-315 systemically. Injecting FS-315 directly is possible but offers no clear advantage and is less commonly available.
  • A key 2009 study demonstrated that AAV-delivered follistatin 344 produced the greatest effects on muscle size and function in nonhuman primates, with increases in muscle fiber size of 15-36% in treated quadriceps (Kota et al. 2009, PubMed 19208403). The study also confirmed tolerability with no adverse effects on cardiac pathology or reproductive function in either sex.